A 48-year-old with newly diagnosed seropositive rheumatoid arthritis has moderate-to-high disease activity without poor prognostic features. Which initial disease‑modifying strategy is recommended?ABegin TNF inhibitor monotherapy immediatelyBHydroxychloroquine monotherapy for all patientsCStart methotrexate monotherapy with treat‑to‑target strategyDStart chronic low‑dose oral prednisone long‑termEDelay DMARD therapy until erosions developCheck my answer